Cingulate

Cingulate Stock-Based Compensation

The Stock-Based Compensation (SBC) of Cingulate (CING) as of Oct 17, 2026 is 1.52 M USD. In the previous year, Stock-Based Compensation (SBC) was 995,484.00 USD — a change of 53.07% (higher).

Stock-Based Compensation

1.52 MUSD

YoY

53.07%

Last updated:

Stock-Based Compensation (SBC) of Cingulate is 2025 1.52 M USD. Stock-Based Compensation (SBC) of Cingulate was 2024 995,484.00 USD. It decreases by 53.07% higher compared to the previous year.

The Cingulate Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2020
0.00 USD
Jan 1, 2021
12.78 M USD
Jan 1, 2022
800,796.00 USD
Jan 1, 2023
812,670.00 USD
Jan 1, 2024
995,484.00 USD
Jan 1, 2025
1.52 M USD
The Cingulate Stock-Based Compensation history
YEARStock-Based CompensationYoY
1.52 MUSD+53.07%
995,484.00USD+22.50%
812,670.00USD+1.48%
800,796.00USD-93.73%
12.78 MUSD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cingulate Stock analysis

What does Cingulate do? Cingulate Inc, headquartered in Kansas City, Kansas, is a US-based biopharmaceutical company operating in the Pharmaceuticals sector. The company focuses on developing and commercializing pharmaceutical products using its precision timed release (PTR) drug delivery platform, specifically targeting attention deficit/hyperactivity disorder (ADHD). Cingulate is developing two lead product candidates, CTx-1301 and CTx-1302, designed as single-tablet formulations with three release phases for children, adolescents, and adults with ADHD. The company, listed on October 7, 2021, employs 15 full-time staff. Cingulate is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cingulate stock

Stock-Based Compensation (SBC) of Cingulate is 1.52 M USD in 2025.

Stock-Based Compensation (SBC) of Cingulate changed from 995,484.00 USD to 1.52 M USD, representing a 53.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Cingulate since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Cingulate historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Cingulate

All Key Metrics — Cingulate